Evidence map›Paper›PMID 39628615›Full record

ArticleEngineering microbiology2022

A specialized role played by a redox cofactor.

Shengling Xie, Lihan Zhang

Abstract read
In one paragraph

Article in Engineering microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shengling XieDepartment of Chemistry, Zhejiang University, Hangzhou 310058, Zhejiang Province, China.
Lihan ZhangKey Laboratory of Precise Synthesis of Functional Molecules of Zhejiang Province, School of Science, Westlake University, 18 Shilongshan Road, Hangzhou 310024, Zhejiang Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The redox cofactor β-nicotinamide adenine dinucleotide (NAD) has been revealed to serve as a building block for the biosynthesis of an alkaloid natural product, altemicidin. The biosynthetic pathway investigation identified a unique pyridoxal pyrophosphate (PLP)-dependent enzyme that utilizes NAD and

Indexed as

BiosynthesisCycloadditionNicotinamide adenine dinucleotidePyridoxal phosphate-dependent enzyme

Identifiers

PMID39628615
PMCPMC11610977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.